Funder
JSPS KAKENHI
Takeda Science Foundation
Bayer Retina Award
The Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder
Alcon Pharma Research Grants
The Foundation for The Advancement of Clinical Medicine
Novartis Pharma Research Grants
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Wykoff CC, Khurana RN, Nguyen QD et al (2021) Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy. Diabetes Care 44(3):748–756. https://doi.org/10.2337/dc20-0413
2. Pe’er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E (1995) Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72(6):638–645
3. Ebihara S, Machida S, Hara Y et al (2021) Relationships between the vascular structure and neural function of the macula in patients with diabetes mellitus. Jpn J Ophthalmol 65(1):77–88. https://doi.org/10.1007/s10384-020-00784-7
4. Chen JT, Chen LJ, Chen SN et al (2020) Management of diabetic macular edema: experts’ consensus in Taiwan. Jpn J Ophthalmol 64(3):235–242. https://doi.org/10.1007/s10384-020-00741-4
5. Das A, McGuire PG, Rangasamy S (2015) Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122(7):1375–1394. https://doi.org/10.1016/j.ophtha.2015.03.024